Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
- Value
- ₹36.67 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
Indraprastha Medical Corporation Limited held its 38th AGM on September 24, 2026. Shareholders considered resolutions including a Rs. 4.00 per share dividend declaration.
Indraprastha Medical Corporation Limited has released its Annual Report for FY 2025-26. The 38th Annual General Meeting is scheduled for September 24, 2026.
Indraprastha Medical Corporation will hold its 38th AGM on September 24, 2026. The company has fixed September 18, 2026, as the record date for dividend and e-voting.
Indraprastha Medical Corporation Ltd reported revenue from operations of ₹406.1 Cr (+11.2% YoY) and net profit of ₹55.9 Cr (+8.5% YoY) for Q1 FY27.
Indraprastha Medical Corporation will hold a board meeting on August 6, 2026. The meeting aims to approve unaudited standalone financial results for June 2026.
ICRA re-affirmed Indraprastha Medical's [ICRA]AA(Stable) and [ICRA]A1+ ratings for ₹162.50 Crore bank facilities. This stable credit profile reflects sustained operational strength and financial health.
Indraprastha Medical Corporation Ltd reported revenue from operations of ₹364.8 Cr (+9.3% YoY) and net profit of ₹41.7 Cr (+1.7% YoY) for Q4 FY26.
Indraprastha Medical Corporation approved audited FY26 results and recommended a 40% dividend. The board proposed Rs 4.00 per share, subject to shareholder approval at AGM.
Indraprastha Medical Corporation recommended a final dividend of ₹4 per share for FY2025-26. The record date for payment will be announced in due course.
Indraprastha Medical Corporation Ltd has scheduled a board meeting on May 12, 2026. The board will consider and approve audited financial results for the year ended March 31, 2026, and recommend a dividend for FY 2025-26.
Indraprastha Medical Corporation Limited has scheduled a Board Meeting for May 12, 2026. The board will consider audited standalone financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 15, 2026.
Indraprastha Medical Corporation Limited confirmed it does not qualify as a 'Large Corporate' for FY 2025-26 under SEBI debt-raising norms. The company reported NIL outstanding long-term borrowings as of March 31, 2026, and maintains an [ICRA]AA credit rating.